Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001636282-26-000078 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 4, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
24,999
Total Value
$853,799.18
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jun 3, 2026 | Exercise/Conversion | 8,333 | $27.46 | $228,824.18 | 8,333 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 3, 2026 | Sale | 8,333 | $75.00 | $624,975.00 | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Jun 3, 2026 | Exercise/Conversion | 8,333 | $0.00 | $0.00 | 313,334 | Direct | โ | View Details |